Serum and cellular pharmacokinetics of clarithromycin 500 mg q.d. and 250 mg b.i.d. in volunteers
- 1 May 1995
- journal article
- clinical trial
- Published by Springer Nature in Infection
- Vol. 23 (3) , 168-172
- https://doi.org/10.1007/bf01793859
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Clarithromycin, ein neues Makrolid-Antibiotikum. Wirksamkeit bei puerperalen Infektionen und Übertritt in die MuttermilchGeburtshilfe und Frauenheilkunde, 1993
- Pharmacokinetics of clarithromycin, a new macrolide, after single ascending oral dosesAntimicrobial Agents and Chemotherapy, 1992
- ClarithromycinDrugs, 1992
- Intracellular distribution and activity of antibioticsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1991
- RoxithromycinClinical Drug Investigation, 1991
- The development of macrolides: clarithromycin in perspectiveJournal of Antimicrobial Chemotherapy, 1991
- Uptake of clarithromycin by rat lung cellsJournal of Antimicrobial Chemotherapy, 1990
- Penetration of macrolides into human polymorphonuclear leucocytesJournal of Antimicrobial Chemotherapy, 1989
- A new macrolide, TE-031 (A-56268), in treatment of experimental Legionnaires' diseaseJournal of Antimicrobial Chemotherapy, 1989
- An in-vitro evaluation of the cellular uptake and infraphagocytic bioactivity of clarithromycin (A-56268, TE-031), a new macrolide antimicrobial agentJournal of Antimicrobial Chemotherapy, 1988